Fierce Biotech4d
Beam gene therapy for protein deficiency passes early safety test, sets efficacy bar in space: analyst
The one-time therapy appears to correct the mutation that causes the disease, known as Alpha-1 antitrypsin deficiency (AATD), ...
BioPharma Dive4d
Beam base editing therapy gets ‘proof of concept’ in rare lung disease
While initial study results suggest Beam's technology can correct alpha-1 antitrypsin deficiency's genetic roots, shares fell ...
Mutated DNA Restored to Normal in Gene Therapy Advance
The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...
Gene Edit Biotech Beam Therapeutics Touts Encouraging Data From Early-Stage Gene Therapy Study In Genetic Disorder, Raises $500 Million Via Equity
Beam Therapeutics reports Phase 1/2 trial data showing BEAM-302's potential in AATD treatment, with dose-dependent mutation ...
The Week8d
What is Proton Beam Therapy, which is used to treat cancer?
Proton Beam Therapy is highly effective for treating tumours in sensitive areas, since by reducing exposure of healthy ...
Managed Healthcare Executive22h
First Clinical Proof of Genetic Mutation Correction for Rare Lung Disease
Early research shows a one-time gene therapy has potential for addressing both the liver and lung disease that patients with ...
pharmaphorum4d
Beam launches $500m financing on base-editing trial data
Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in ...
Rediff Money11d
Apollo Hospitals Partners with IBA for Proton Beam Therapy
Apollo Hospitals has partnered with Ion Beam Applications (IBA) to introduce Proteus One proton beam therapy solutions for ...
GlobalData on MSN9d
Apollo Hospitals to procure proton therapy solution from IBA
India-based Apollo Hospitals Enterprise has signed a term sheet with Ion Beam Applications (IBA) to procure one ProteusONE ...
Apollo Hospitals partners with Ion Beam Applications for proton therapy
Apollo Hospitals on Tuesday said it has tied up with Ion Beam Applications to introduce proton beam therapy solutions for ...
MedCity News5d
Beam Base Editor’s Early Data in Rare Liver Disease Tee Up $500M Stock Sale in Tough Market
A Beam Therapeutics gene-editing therapy designed to fix a mutation at the root of a rare liver protein deficiency now has early signs of efficacy along with safety data that ease some concerns ...